pc945
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2017 (NCT02715570)
Timeline
Indications
Mechanism of action
- ErgosterolBLOCKER
Ergosterol blocker
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pc945
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05238116 | Phase 3 | Jun 14, 2022 | Pulmocide Ltd |
| NCT05037851 | Phase 2 | Nov 19, 2021 | Pulmocide Ltd |
| NCT03905447 | Phase 2 | Jun 30, 2019 | Pulmocide Ltd |
| NCT03870841 | Phase 2 | Apr 3, 2019 | Pulmocide Ltd |
| NCT03745196 | Phase 2 | Nov 15, 2018 | Pulmocide Ltd |
| NCT02715570 | Phase 1 | Aug 1, 2017 | Pulmocide Ltd |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pulmocide Ltd | For profit | 6 | 6 | 3 | 2017 |
1 organizations
Page 1 / 1